Advanced Clinical Decision Support Platforms Market by Type (Therapeutic and Diagnostic), Model (Knowledge based and Non-Knowledge based), and Setting (Hospitals and Ambulatory care): Global Opportunity Analysis and Industry Forecast, 2021–2030
- ALL4676744
- 190 Pages
- August 2021
- Medical Devices
Advanced clinical decision support platform, provides an actionable information for improving the decision making abilities of the health professionals. It is a type of system that offers health information technology to doctors, staff, patients, and other individuals with knowledge and person-specific information that is intelligently filtered or provided at the right moment to enhance health and health care. Clinical decision support system (CDSS) is a set of tools designed to assist clinicians make better decisions in the clinic. Furthermore, computerized alerts and reminders to care providers and patients, as well as clinical guidelines, condition-specific order sets, targeted patient data reports & summaries, documentation templates, diagnostic assistance, and contextually appropriate reference information, are some of the tools available. According to Robert Hayward of the Centre for Health Evidence; clinical decision support systems link health observations with health knowledge to influence health choices by clinicians for improved health care.
The key factors that drive the market growth are rise in geriatric population as it leads to rise in chronic diseases, increased health assessments, rise in number of hospitals, rise in medical errors, growing demand for data driven technologies, number of emergency department (ED) visits. The healthcare system is also expected to witness the shortage of physicians in the upcoming years thus enhancing the need of decision making tools in order to effectively manage physician time and prevent the overcrowding of hospitals due to increased medical needs. It has significantly improved the clinical results and facilitated reduction in healthcare costs, thus further boosting the market growth. Despite the advantages of the clinical decision support platforms, there are certain factors that may restrain the market growth such as the adoption rate of these tools is modest due to implementation problems. Furthermore, physicians view CDSS technologies as a threat to their professional autonomy.
The advanced clinical decision support platforms market is segmented on the basis of type, application, setting and region. By type, it is bifurcated into therapeutic and diagnostic. By application, it is bifurcated into advanced CDSS and conventional CDSS. By setting type, it is bifurcated into hospitals and ambulatory care. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for the largest market share in 2020 and is expected to retain its dominance throughout the forecast period. This is attributed to increase in geriatric population, rise in hospitals and emergency department visits and growth in technological advancements for CDSS. In addition, Asia-Pacific is expected to witness a significant growth during the forecast period, owing to the increasing population in regions such as China and India. However, LAMEA is expected to emerge as a lucrative area with maximum growth potential, due to the improvement in healthcare facilities, available disposable income, and rapid development of economic conditions.
Some of the key players operating in the advanced clinical decision support platforms market are Allscripts Healthcare Solutions, Cerner, Epic, Elsevier B.V., IBM Watson, Meditech, NextGen Healthcare, Siemens Healthineers, Wolters Kluwer Health and Zynx Health.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global advanced clinical decision support platforms market along with the current trends and future estimations to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps to understand the application and products of Bronchoscopy used across the globe.
• Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
• BY Type
o • Therapeutic
o • Diagnostic
• By Model
o Knowledge based
o Non-Knowledge based
• BY SETTING
• Hospitals
• Ambulatory care
• By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
o
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Growing incidence of medication error
3.5.1.2. Increase in more patient specific platforms
3.5.1.3. Rapid increase in aging population and subsequent rise in the number of chronic diseases
3.5.2. Restraint
3.5.2.1. Data security concerns related to cloud based CDSS
3.5.2.2. Increase in concerns regarding the patient data safety & security
3.5.3. Opportunity
3.5.3.1. Emerging Countries
3.5.4. Impact analysis
3.6. COVID-19 impact analysis on the advanced clinical decision support platforms market
CHAPTER 4: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Therapeutic
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Diagnostic
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
CHAPTER 5: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL
5.1. Overview
5.1.1. Market size and forecast
5.2. Knowledge based
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Non-knowledge based
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
CHAPTER 6: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Ambulatory Care Settings
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
CHAPTER 7: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast, by region
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by type
7.2.3. Market size and forecast, by Model
7.2.4. Market size and forecast, by setting
7.2.5. Market size and forecast, by country
7.2.5.1. U.S
7.2.5.1.1. U.S. market size and forecast, by type
7.2.5.1.2. U.S. market size and forecast, by Model
7.2.5.1.3. U.S. market size and forecast, by setting
7.2.5.2. Canada
7.2.5.2.1. Canada market size and forecast, by type
7.2.5.2.2. Canada market size and forecast, by Model
7.2.5.2.3. Canada market size and forecast, by setting
7.2.5.3. Mexico
7.2.5.3.1. Mexico market size and forecast, by type
7.2.5.3.2. Mexico market size and forecast, by Model
7.2.5.3.3. Mexico market size and forecast, by setting
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by type
7.3.3. Market size and forecast, by Model
7.3.4. Market size and forecast, by setting
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Germany market size and forecast, by type
7.3.5.1.2. Germany market size and forecast, by Model
7.3.5.1.3. Germany market size and forecast, by setting
7.3.5.2. France
7.3.5.2.1. France market size and forecast, by type
7.3.5.2.2. France market size and forecast, by Model
7.3.5.2.3. France market size and forecast, by setting
7.3.5.3. UK
7.3.5.3.1. UK market size and forecast, by type
7.3.5.3.2. UK market size and forecast, by Model
7.3.5.3.3. UK market size and forecast, by setting
7.3.5.4. Italy
7.3.5.4.1. Italy market size and forecast, by type
7.3.5.4.2. Italy market size and forecast, by Model
7.3.5.4.3. Italy market size and forecast, by setting
7.3.5.5. Spain
7.3.5.5.1. Spain market size and forecast, by type
7.3.5.5.2. Spain market size and forecast, by Model
7.3.5.5.3. Spain market size and forecast, by setting
7.3.5.6. Rest of Europe
7.3.5.6.1. Rest of Europe market size and forecast, by type
7.3.5.6.2. Rest of Europe market size and forecast, by Model
7.3.5.6.3. Rest of Europe market size and forecast, by setting
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by type
7.4.3. Market size and forecast, by Model
7.4.4. Market size and forecast, by setting
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Japan market size and forecast, by type
7.4.5.1.2. Japan market size and forecast, by Model
7.4.5.1.3. Japan market size and forecast, by setting
7.4.5.2. China
7.4.5.2.1. China market size and forecast, by type
7.4.5.2.2. China market size and forecast, by Model
7.4.5.2.3. China market size and forecast, by setting
7.4.5.3. India
7.4.5.3.1. India market size and forecast, by type
7.4.5.3.2. India market size and forecast, by Model
7.4.5.3.3. India market size and forecast, by setting
7.4.5.4. Australia
7.4.5.4.1. Australia market size and forecast, by type
7.4.5.4.2. Australia market size and forecast, by Model
7.4.5.4.3. Australia market size and forecast, by setting
7.4.5.5. South Korea
7.4.5.5.1. South Korea market size and forecast, by type
7.4.5.5.2. South Korea market size and forecast, by Model
7.4.5.5.3. South Korea market size and forecast, by setting
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Rest of Asia-Pacific market size and forecast, by type
7.4.5.6.2. Rest of Asia-Pacific market size and forecast, by Model
7.4.5.6.3. Rest of Asia-Pacific market size and forecast, by setting
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by type
7.5.3. Market size and forecast, by Model
7.5.4. Market size and forecast, by setting
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Brazil market size and forecast, by type
7.5.5.1.2. Brazil market size and forecast, by Model
7.5.5.1.3. Brazil market size and forecast, by setting
7.5.5.2. Saudi
7.5.5.2.1. Saudi market size and forecast, by type
7.5.5.2.2. Saudi market size and forecast, by Model
7.5.5.2.3. Saudi market size and forecast, by setting
7.5.5.3. South Africa
7.5.5.3.1. South Africa market size and forecast, by type
7.5.5.3.2. South Africa market size and forecast, by Model
7.5.5.3.3. South Africa market size and forecast, by setting
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Rest of LAMEA market size and forecast, by type
7.5.5.4.2. Rest of LAMEA market size and forecast, by Model
7.5.5.4.3. Rest of LAMEA market size and forecast, by setting
CHAPTER 8: COMPANY PROFILES
8.1. ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. CERNER CORPORATION
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. RELX GROUP (ELSEVIER B.V.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. EPIC SYSTEM CORPORATION
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. IBM WATSON HEALTH
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. MEDITECH
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.7. NEXTGEN HEALTHCARE, INC.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. SIEMENS HEALTHINEERS AG
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. WOLTERS KLUWER HEALTH
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. ZYNX HEALTH
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
TABLE 01. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02. THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS DIAGNOSTIC MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2020–2030 ($MILLION)
TABLE 05. KNOWLEDGE BASED ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06. NON-KNOWLEDGE BASED ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 07. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTINGS, 2020–2030 ($MILLION)
TABLE 08. HOSPITALS ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 09. AMBULATORY CARE SETTING ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 10. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY REGION, 2020-2030, ($MILLION)
TABLE 11. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 12. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 13. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 14. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY COUNTRY, 2020-2030, ($MILLION)
TABLE 15. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 16. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 17. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 18. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 19. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 20. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 21. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 22. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 23. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 24. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 25. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 26. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 27. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY COUNTRY, 2020-2030, ($MILLION)
TABLE 28. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 29. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 30. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 31. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 32. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 33. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 34. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 35. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 36. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 37. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 38. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 39. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 40. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 41. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 42. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 43. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 44. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 45. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 46. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 47. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 48. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 49. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY COUNTRY, 2020-2030, ($MILLION)
TABLE 50. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 51. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 52. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 53. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 54. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 55. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 56. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 57. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 58. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 59. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 60. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 61. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 62. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 63. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 64. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 68. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 69. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 70. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 71. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY COUNTRY, 2020-2030, ($MILLION)
TABLE 72. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 73. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 74. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 75. SAUDI ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 76. SAUDI ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 77. SAUDI ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 78. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 79. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 80. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 81. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY TYPE, 2020-2030, ($MILLION)
TABLE 82. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY MODEL, 2020-2030, ($MILLION)
TABLE 83. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY SETTING, 2020-2030, ($MILLION)
TABLE 84. ALLSCRIPTS: COMPANY SNAPSHOT
TABLE 85. ALLSCRIPTS: OPERATING SEGMENTS
TABLE 86. ALLSCRIPTS: PRODUCT PORTFOLIO
TABLE 87. CERNER: COMPANY SNAPSHOT
TABLE 88. CERNER: OPERATING SEGMENTS
TABLE 89. CERNER: PRODUCT PORTFOLIO
TABLE 90. RELX: COMPANY SNAPSHOT
TABLE 91. RELX: OPERATING SEGMENTS
TABLE 92. RELX: PRODUCT PORTFOLIO
TABLE 93. EPIC SYSTEMS: COMPANY SNAPSHOT
TABLE 94. EPIC SYSTEMS: OPERATING SEGMENTS
TABLE 95. EPIC SYSTEMS: PRODUCT PORTFOLIO
TABLE 96. WATSON: COMPANY SNAPSHOT
TABLE 97. WATSON: OPERATING SEGMENTS
TABLE 98. WATSON: PRODUCT PORTFOLIO
TABLE 99. MEDITECH: COMPANY SNAPSHOT
TABLE 100. MEDITECH: OPERATING SEGMENTS
TABLE 101. MEDITECH: PRODUCT PORTFOLIO
TABLE 102. NEXTGEN: COMPANY SNAPSHOT
TABLE 103. NEXTGEN: OPERATING SEGMENTS
TABLE 104. NEXTGEN: PRODUCT PORTFOLIO
TABLE 105. SIEMENS: COMPANY SNAPSHOT
TABLE 106. SIEMENS: OPERATING SEGMENTS
TABLE 107. SIEMENS: PRODUCT PORTFOLIO
TABLE 108. WOLTERS KLUWER: COMPANY SNAPSHOT
TABLE 109. WOLTERS KLUWER: OPERATING SEGMENTS
TABLE 110. WOLTERS KLUWER: PRODUCT PORTFOLIO
TABLE 111. ZYNX HEALTH: COMPANY SNAPSHOT
TABLE 112. ZYNX HEALTH: OPERATING SEGMENTS
TABLE 113. ZYNX HEALTH: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
